Armistice Capital »

Louisiana-Pacific Corporation shares owned by Armistice Capital

Quarter-by-quarter ownership of Louisiana-Pacific Corporation (LPX) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Louisiana-Pacific Corporation

Tip: Access up to 7 years of quarterly data

All positions including Louisiana-Pacific Corporation held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Louisiana-Pacific Corporation by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $288k 3.7k 78.66

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Louisiana-Pacific Corporation

BlackRock
Berkshire Hathaway
T. Rowe Price Associates
59 North Capital Management
FMR
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Dimensional Fund Advisors
Citadel Advisors
Fiduciary Management
Maple Rock Capital Partners
Franklin Resources
Point72 Asset Management
Geode Capital Management

View all funds holding Louisiana-Pacific Corporation